Olema Pharmaceuticals, Inc. OLMA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s total liabilities?
- Olema Pharmaceuticals, Inc. (OLMA) reported total liabilities of $50.17M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s total liabilities changed year-over-year?
- Olema Pharmaceuticals, Inc.'s total liabilities increased by 91.6% year-over-year, from $26.19M to $50.17M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s total liabilities has grown at a 64.3% compound annual growth rate (CAGR), from $4.59M to $54.87M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.